Both JunB and CXCR4 have been shown to be overexpressed breast cancer (Kallergi et al., 2019, 2020), and CXCR4 has been implicated in tumor progression in pancreatic cancer (Dubrovska et al., 2012). Here, CXCR4 is linked to breast carcinoma.